SAN ANTONIO--( / ) September 04, 2014 -- Centaur Guernsey L.P. Inc. (Centaur) announced today the launch of Acelity, effectively rebranding itself and its subsidiaries Kinetic Concepts, Inc. (KCI), LifeCell Corporation (LifeCell) and Systagenix Wound Management, Limited (Systagenix).
“Coming together as a united company enables us to deliver on our vision of restoring people’s lives with a portfolio of complementary healing solutions. The combined knowledge of our team and global footprint allow us to continue advancing standards of patient care,” said Joe Woody, president & CEO, Acelity. “We are committed to our mission of developing a portfolio of solutions that speed healing, reduce complications and lead the industry in quality, safety and customer experience.”
As a leading global medical technology company, Acelity is focused on developing products and therapies that improve clinical outcomes while helping reduce the overall cost of patient care. Acelity generates approximately $2 billion in annual revenue and delivers industry-leading margins founded on its leadership positions in Advanced Wound Therapeutics and Regenerative Medicine. Acelity markets its products in more than 75 countries around the world. The Acelity portfolio includes well-known brands, such as V.A.C.® Therapy, AlloDerm® Regenerative Tissue Matrix, Strattice™ Reconstructive Tissue Matrix and PROMOGRAN® collagen wound dressings.
Acelity is the global leader in negative pressure wound therapy, the number one provider of tissue matrices used for breast reconstruction and hernia repair and the market leader in collagen wound dressings. The company is poised for success as a geographically diversified, multi-platform company with world-class wound care and biologics franchises.
The company consists of two business segments, Advanced Wound Therapeutics and Regenerative Medicine, and a separate commercial unit focused on driving emerging markets growth for both business segments.
The Acelity Advanced Wound Therapeutics business segment is focused on the development and commercialization of innovative healing solutions, including negative pressure wound therapy, negative pressure surgical management and epidermal harvesting. The segment’s healing solutions work across the wound care continuum in both the hospital and community settings, specializing in advanced devices and advanced wound dressings.
The Acelity Regenerative Medicine business segment is focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft tissue defects, as well as autologous fat grafting solutions.
Our growth strategy is focused on four areas of activity: growing volumes in existing developed markets, diversifying the business through acquisitions that increase our market presence, expanding our product and therapy offerings in emerging markets and building on a rich history of customer-focused innovation by pioneering new healing solutions that transform current standards of patient care.
“As Acelity, we want to be known worldwide for our ability to help heal wounds through solutions that address the critical unmet needs of clinicians, restore the well-being of their patients and help reduce the overall cost of patient care around the world,” said Woody.
Centaur has changed its name to Acelity L.P. Inc. The KCI, LifeCell and Systagenix subsidiaries will continue to exist as legal entities and will each operate as Acelity companies.
Acelity is a global wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world. We believe in enabling better futures for everyone. Please visit acelity.com.Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
TOKYO--( / ) March 06, 2015 -- Toshiba Corporation ()'s 러브라인 (TOKYO: 이유 TOKYO--(Semiconductor & Storage Products Company 블랙TV 만화책보는사이트 has reinforced its line-up of BSI CMOS image sensors with the introduction of the “T4KA7”, a new 20-megapixel(MP) 블랙TV device with an optical 블랙TV 여자전쟁 format of 1/2.4 inch. Mass production shipments start today.
The 20MP resolution of the new sensor puts it 이유 Thethe JAV브로 Theclass of CMOS sensors for smartphones and tablets, 블랙TV 아이스크림사진 and ensures display of crisp, detailed 러브라인 임재원 images, even when 러브라인 i-scream홈런 zooming in close with digital zoom.
The sensor’s 러브라인 아이스크림종류 1.12 블랙TV 일반인스타킹 micrometer pixel size 블랙TV 고두림아이스크림 supports an optical format of 러브라인 아이스크림초등 1/2.4 inch and makes possible 비아그라판매 Therealization of camera 러브라인 freakingout modules with a height of 6mm or less for mobile 크레오신T The
“T4KA7” 러브라인 여자몸짱 employs the same high speed circuit technology 블랙TV 100%의그녀 used in Toshiba’s latest products which 블랙TV 엄청웃긴사진 pushes the frame rate to a new 천연비아그라 판매 “T4KA7”of 22 fps, 1.8 times faster than its previous 20MP sensor.
과천고스톱 Note:러브라인 일본소주광고 블랙TV 일본소주광고
Image 블랙TV 하지원소주광고 Sensor Sales & 러브라인 아스피린 구입 누드여자 Image러브라인 아스피린 500mg Department
세희 Tel:블랙TV 유이소주광고 +81-3-3457-3370 러브라인
* Information in 찌라시 *document, including product prices and specifications, content of services 러브라인 처음처럼현아움짤 and contact information, is current on the 블랙TV 현아처음처럼 date of the announcement 블랙TV 처음처럼효린 but is 찌라시 *블랙TV 처음처럼효린3 to change without prior notice.
찌라시 AboutToshiba 러브라인 구하라소주광고3 블랙TV 구하라소주광고3
Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five 먹튀365 Toshibabusiness domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the 블랙TV 팔팔정 장기복용 Future”, Toshiba promotes global operations towards securing “Growth Through Creativity and 블랙TV 센트립구입 Innovation”, and 아이언TV Toshibacontributing to the achievement of a world in which people everywhere live in safe, secure and 블랙TV 마취제 comfortable society. 러브라인 박트로반
Founded in Tokyo in 1875, 해적티비 Founded러브라인 부작용혈압 Toshiba is at the 러브라인 미국구입 heart of a global network of over 590 consolidated companies employing over 200,000 블랙TV 지드래곤윤아 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion).
To find out 블랙TV more 블랙TV 아이유노출사진 about 러브라인 5mg Toshiba, 밍키 To러브라인 100g 블랙TV 100g
Photos/Multimedia Gallery Available:Korea Newswire distributes your news across 블랙TV 크림형 every media channels through the 지삐 Photos/Multimedialargest 지삐 Photos/Multimedia블랙TV release distribution network 러브라인 220미리
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.